Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

33.7K
Overview
33.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

182
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
182
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Hypersensitivities01:30

Hypersensitivities

8.4K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
8.4K
Cross-reactivity00:42

Cross-reactivity

33.9K
Overview
33.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When knowing costs too much: a health-economic evaluation of failed 95044 reimbursement for patch testing in allergic contact dermatitis.

The journal of allergy and clinical immunology. In practice·2026
Same author

Balancing patient perspectives and evidence in food protein-induced enterocolitis syndrome (FPIES).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Feed the Good Wolf: Motivational Interviewing, Cognitive Behavioral Therapy, and Mindset.

The journal of allergy and clinical immunology. In practice·2026
Same author

Values-Based Healthcare and the Quintuple Aim: Connection, Compassion, Equity, & Stewardship.

The journal of allergy and clinical immunology. In practice·2026
Same author

The pro-doc-tivity pause: Health economic benefits of collegial connection.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

The epinephrine that works is the one you use: Access matters.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same journal

For health, for beauty, or both? navigating trends as adolescent clinicians.

Current opinion in pediatrics·2026
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
See all related articles

Related Experiment Video

Updated: Apr 6, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

4.1K

New developments in allergen immunotherapy.

Anusha Vadlamudi1, Marcus Shaker

  • 1aDepartment of Pediatrics, Children's Hospital at Dartmouth, New Hampshire, USA bSection of Allergy, Asthma, and Immunology, Department of Pediatrics, Children's Hospital at Dartmouth, Lebanon, New Hampshire, USA.

Current Opinion in Pediatrics
|August 5, 2015
PubMed
Summary
This summary is machine-generated.

Allergen immunotherapy, including subcutaneous (SCIT) and sublingual (SLIT) options, offers effective treatments for allergic rhinoconjunctivitis and asthma. New SLIT tablets provide convenient, well-tolerated options for grass and ragweed allergies.

More Related Videos

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

13.0K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.2K

Related Experiment Videos

Last Updated: Apr 6, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

4.1K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

13.0K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.2K

Area of Science:

  • Immunology
  • Allergy & Asthma Research
  • Dermatology

Background:

  • Allergic rhinitis, conjunctivitis, and asthma significantly affect quality of life and incur substantial economic costs.
  • Allergen immunotherapy is the sole therapeutic approach that modifies the immune response to allergens, leading to symptom reduction upon natural exposure.

Purpose of the Study:

  • To review recent advancements in allergen immunotherapy for allergic diseases.
  • To summarize the efficacy and safety of current and emerging immunotherapy treatments.

Main Methods:

  • Review of current literature on subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT).
  • Analysis of evidence regarding SCIT for atopic dermatitis and SLIT for grass and ragweed allergies.
  • Examination of ongoing research in oral food allergen immunotherapy (OIT).

Main Results:

  • SCIT is a disease-modifying treatment for allergic rhinoconjunctivitis and asthma with a low risk of complications. Evidence suggests SCIT may benefit select atopic dermatitis patients, especially those with dust mite sensitivity.
  • Sublingual immunotherapy (SLIT) tablets are available for grass and ragweed allergies, demonstrating a favorable safety profile compared to SCIT and similar long-term effectiveness. SLIT allows for convenient daily home administration and can be used pre-seasonally or seasonally.
  • Research into oral food allergen immunotherapy (OIT) is ongoing for food allergies, with some patients achieving sustained unresponsiveness, though its use is currently limited to research protocols.

Conclusions:

  • New, well-tolerated, and effective immunotherapy options are available for convenient treatment of asthma and allergic rhinoconjunctivitis related to grass and ragweed allergies.
  • SCIT remains a viable option for polysensitized individuals and potentially for some atopic dermatitis patients.
  • Further research is underway to develop novel treatments for food allergies.